330
Participants
Start Date
August 18, 2025
Primary Completion Date
January 4, 2029
Study Completion Date
July 15, 2029
Tarlatamab
Tarlatamab will be administered as an intravenous (IV) infusion.
Durvalumab
Durvalumab will be administered as an IV infusion.
Carboplatin
Carboplatin will be administered as an IV infusion.
Etoposide
Etoposide will be administered as an IV infusion.
RECRUITING
Hopitaux universitaires de Geneve, Geneva
RECRUITING
Reformatus Pulmonologiai Centrum, Törökbálint
RECRUITING
Chris OBrien Lifehouse, Camperdown
RECRUITING
Rigshospitalet, Copenhagen
RECRUITING
Monash Medical Centre, Clayton
RECRUITING
Matrai Gyogyintezet, Gyöngyös
RECRUITING
Universitaetsklinikum Krems, Krems
RECRUITING
Universitaetsspital Basel, Basel
RECRUITING
Regionshospitalet Godstrup, Herning
RECRUITING
National Cancer Center, Goyang-si Gyeonggi-do
RECRUITING
Taipei Veterans General Hospital, Taipei
RECRUITING
LungenClinic Grosshansdorf GmbH, Großhansdorf
RECRUITING
West Virginia University Health Sciences Center, Morgantown
RECRUITING
Chungbuk National University Hospital, Cheongju Chungbuk
RECRUITING
Bagcilar Medipol Mega Universite Hastanesi, Istanbul
RECRUITING
Goztepe Prof Dr Suleyman Yalcin Sehir Hastanesi, Istanbul
RECRUITING
Centro Ricerche Cliniche Di Verona Societa responsabilita limitata, Verona
RECRUITING
Baptist Cancer Center, Memphis
RECRUITING
Centre Hospitalier Universitaire de Nantes - Hopital Nord Laennec, Saint-Herblain
RECRUITING
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori, Meldola (FC)
RECRUITING
Sakarya Egitim ve Arastirma Hastanesi, Sakarya
RECRUITING
European Interbalkan Medical Center, Thessaloniki
RECRUITING
Iatriko Diavalkaniko Thessalonikis, Thessaloniki
RECRUITING
IRCCS Istituto Tumori Giovanni Paolo II, Bari
RECRUITING
National Cheng Kung University Hospital, Tainan City
RECRUITING
Universitaetsklinikum Wuerzburg, Würzburg
RECRUITING
Beijing Cancer Hospital, Beijing
RECRUITING
Beijing Cancer Hospital, Beijing
RECRUITING
Jiamusi Cancer Hospital, Jiamusi
RECRUITING
Shanghai Chest Hospital, Shanghai
RECRUITING
Shandong Cancer Hospital, Jinan
RECRUITING
Tianjin Cancer Hospital, Tianjin
RECRUITING
The First Affiliated Hospital Of Ningbo University, Ningbo
RECRUITING
Jiangxi Cancer hospital, Nanchang
RECRUITING
The First Affiliated Hospital of Nanchang University, Nanchang
RECRUITING
Fujian Cancer Hospital, Fuzhou
RECRUITING
The Second Attached Hospital Of Fujian Medical University, Quanzhou
RECRUITING
Shanxi Provincial Cancer Hospital, Taiyuan
RECRUITING
Queen Mary Hospital, The University of Hong Kong, Hong Kong
RECRUITING
Prince of Wales Hospital, Chinese University of Hong Kong, Shatin, New Territories
RECRUITING
Azienda Ospedaliera San Giovanni Addolorata, Roma
RECRUITING
Kyushu University Hospital, Fukuoka
RECRUITING
Kurume University Hospital, Kurume-shi
RECRUITING
National Hospital Organization Hokkaido Cancer Center, Sapporo
RECRUITING
Hyogo Cancer Center, Akashi-shi
RECRUITING
Okayama University Hospital, Okayama
RECRUITING
Kansai Medical University Hospital, Hirakata-shi
RECRUITING
Saitama Medical University International Medical Center, Hidaka-shi
RECRUITING
Wakayama Medical University Hospital, Wakayama
RECRUITING
Severance Hospital Yonsei University Health System, Seoul
RECRUITING
Hospital Universitari Vall d Hebron, Barcelona
RECRUITING
Memorial Ankara Hastanesi, Ankara
RECRUITING
Ankara Bilkent Sehir Hastanesi, Ankara
Lead Sponsor
Collaborators (1)
AstraZeneca
INDUSTRY
Amgen
INDUSTRY